Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 3

Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels

Pages
299–307
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Receiver operating char-acteristic curve for plasma bile acid levels at cutoff value of 75.5 μmol/L had a 59% specificity and 97.4% sensitivity as a predictor of advanced hepatic fibrosis (AUROC=0.78%).Conclusion: We concluded that Egyptian patients having chronic hepatitis C genotype 4 with CC genotype of ABCB11 SNP 1331T>C and high plasma bile acid levels at cutoff value of 75.5 μmol/L were associated with advanced hepatic fibrosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Chronic hepatitis C (CHC)-related mortality generally results from cirrhosis and subsequent complications.
📊
Key Findings & Data:We aimed to investigate the potential role of plasma bile acid levels and ABCB11 1331T>C (V444A, rs2287622) (ATP-binding cassette subfamily B, member 11) gene polymorphism in fibrosis prediction in CHC genotype 4 patients.Materials and Methods: This case control study included 85 healthy control and the following 225 subjects: 170 adult patients infected with hepatitis C virus (HCV) and categorized into three groups according to liver biopsy; no fibrosis group (F0) (n=33), early fibrosis group (F1-F2) (n=61), and advanced fibrosis group (F3-F4) (n=76).
💡
Conclusion & Impact:Receiver operating char-acteristic curve for plasma bile acid levels at cutoff value of 75.5 μmol/L had a 59% specificity and 97.4% sensitivity as a predictor of advanced hepatic fibrosis (AUROC=0.78%).Conclusion: We concluded that Egyptian patients having chronic hepatitis C genotype 4 with CC genotype of ABCB11 SNP 1331T>C and high plasma bile acid levels at cutoff value of 75.5 μmol/L were associated with advanced hepatic fibrosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Chronic hepatitis C (CHC)-related mortality generally results from cirrhosis and subsequent complications. We aimed to investigate the potential role of plasma bile acid levels and ABCB11 1331T>C (V444A, rs2287622) (ATP-binding cassette subfamily B, member 11) gene polymorphism in fibrosis prediction in CHC genotype 4 patients.Materials and Methods: This case control study included 85 healthy control and the following 225 subjects: 170 adult patients infected with hepatitis C virus (HCV) and categorized into three groups according to liver biopsy; no fibrosis group (F0) (n=33), early fibrosis group (F1-F2) (n=61), and advanced fibrosis group (F3-F4) (n=76). Fasting bile acid levels, hepatitis C virus (HCV) genotyping, and ABCB11 1331T>C gene polymorphism were assessed.Results: The frequency of the variant homozygote genotype CC in advanced fibrosis was significantly higher than that in early fibro-sis (48.7% vs. 36.1%) (odd ratio, OR =2.58; 95% confidence interval, CI=1.07-6.20; p=0.03). C allele was significantly represented in advanced fibrosis (65.8%) compared with that in early fibrosis (51.6%) (OR=1.80, 95% CI=1.10-2.93, p=0.01). A significant elevation of plasma bile acid levels in advanced fibrosis was observed compared with those in early fibrosis (p≤0.001). Receiver operating char-acteristic curve for plasma bile acid levels at cutoff value of 75.5 μmol/L had a 59% specificity and 97.4% sensitivity as a predictor of advanced hepatic fibrosis (AUROC=0.78%).Conclusion: We concluded that Egyptian patients having chronic hepatitis C genotype 4 with CC genotype of ABCB11 SNP 1331T>C and high plasma bile acid levels at cutoff value of 75.5 μmol/L were associated with advanced hepatic fibrosis.

🔖

Cite This Article

BESHEER, T., ARAFA, M., EL-MAKSOUD, M. A., ELALFY, H., HASSON, A., ZALATA, K., ELKASHEF, W., ELSHAHAWY, H., RAAFAT, D., ELEMSHATY, W., ELSAYED, E., ZAGHLOUL, H., RAZEK, A. A., EL-BENDARY, M. (2018). Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 3, 299–307. https://ajindex.com/articles/410156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Meier Y, Zodan T, Lang C, et al. Increased susceptibility for in-trahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J Gastroenterol 2008
  2. [CrossRef] 18. Dixon PH, van Mil SW, Chambers J, et al. Contribution of vari-ant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009
  3. [CrossRef] 17. Telbisz A, Homolya L. Recent advances in the exploration of the bile salt expert pump (BSEP/ABCB11) function. Expert Opin Ther Targets 2015
  4. [CrossRef] 16. Stieger B, Geier A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opin Drug Metab Toxicol 2011
  5. [CrossRef] 15. Iwata R, Baur K, Stieger B, et al. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clinical Science 2011
  6. [CrossRef] 14. Besheer T, El-Bendary M, Elalfy H, et al. Prediction of Fibrosis Pro-gression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors. J Interferon Cytokine Res 2017
  7. [CrossRef] 13. Feld JJ, Liang TJ. Hepatitis C: identifying patients with progres-sive liver injury. Hepatology 2006
  8. [CrossRef] 12. Friedman SL, Rockey DC, Bissell DM. Hepatic fibrosis 2006: Re-port of the Third AASLD Single Topic Conference. Hepatology 2007
  9. [CrossRef] 11. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis pro-gression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997
  10. [CrossRef] 10. Bedossa P, Poynard T, The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. Hepatology 1996
  11. [CrossRef] 9. Elahi E, Pourmand N, Chaung R, et al. Determination of hepatitis C virus genotype by Pyrosequencing. J Virol Methods 2003
  12. [CrossRef] 8. Ramm GA, Shepherd RW, Hoskins AC, et al. Fibrogenesis in pe-diatric cholestatic liver disease: role of taurocholate and hepato-cyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009
  13. [CrossRef] 7. Strautnieks SS, Byrne JA, Pawlikowska L, et al. Severe bile salt export pump deficiency: 82 diff